<table class="infobox infobox-protein">
MAP4 Protein (Microtubule-Associated Protein 4)
Introduction MAP4 (Microtubule-Associated Protein 4) , encoded by the [MAP4](/genes/map4) gene, is a prominent microtubule-associated protein that plays critical roles in neuronal function, cell division, and intracellular transport. As a member of the MAP family, MAP4 shares structural and functional similarities with [tau protein](/proteins/tau), which is heavily implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis. This connection makes MAP4 a protein of significant interest in neurodegenerative disease research [1].
Structure MAP4 is a large protein (~210 kDa) with a modular domain structure:
... <table class="infobox infobox-protein">
MAP4 Protein (Microtubule-Associated Protein 4)
Introduction MAP4 (Microtubule-Associated Protein 4) , encoded by the [MAP4](/genes/map4) gene, is a prominent microtubule-associated protein that plays critical roles in neuronal function, cell division, and intracellular transport. As a member of the MAP family, MAP4 shares structural and functional similarities with [tau protein](/proteins/tau), which is heavily implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis. This connection makes MAP4 a protein of significant interest in neurodegenerative disease research [1].
Structure MAP4 is a large protein (~210 kDa) with a modular domain structure:
N-terminal Projection Domain
Projects outward from the microtubule surface
Contains multiple phosphorylation sites
Interacts with other cytoskeletal proteins
Regulates microtubule bundling and organization
C-terminal Microtubule-binding Domain
Contains three to four tau-like repeat motifs (PXXP)
Binds to tubulin heterodimers
Mediates microtubule stabilization
Contains the microtubule polymerization promoting protein (MIPP) region
Phosphorylation Sites
Multiple serine/threonine phosphorylation sites
Phosphorylation regulates microtubule binding affinity
Key sites: Ser696, Ser787, Ser1133 (human MAP4)
The structural similarity to tau protein (~50% homology in microtubule-binding domain) has important implications for understanding tauopathies.
Normal Function
Microtubule Stabilization MAP4 is a major stabilizer of microtubules in non-neuronal cells and [neurons](/entities/neurons):
Prevents depolymerization : Binds along microtubule length, stabilizing protofilamentsPromotes polymerization : Facilitates tubulin assembly into microtubulesRegulates dynamics : Modifies microtubule instabilityIntracellular Transport By stabilizing microtubules, MAP4 indirectly supports:
Axonal transport : Facilitates vesicle and organelle movement along axonsDendritic transport : Supports synaptic vesicle traffickingCytoplasmic transport : Enables long-distance transport in neuronsCell Division In dividing cells, MAP4:
Stabilizes mitotic spindles
Regulates chromosome segregation
Controls cell cycle progression
Neuronal Development MAP4 plays roles in:
Axon guidance
Dendrite formation
Synapse development
Role in Neurodegeneration
Alzheimer's Disease MAP4 is closely connected to tau pathology in AD:
Hyperphosphorylation : Like tau, MAP4 becomes hyperphosphorylated in AD brains:
[GSK-3β](/entities/gsk3-beta) phosphorylates MAP4 at multiple sites
[CDK5](/proteins/cdk5) also contributes to MAP4 phosphorylation
Phosphorylation reduces microtubule binding
Tau-like Pathology : MAP4 exhibits tau-like behavior:
Forms aggregates in AD brains
Colocalizes with neurofibrillary tangles
May contribute to tangle formation
Axonal Transport Defects : MAP4 dysfunction contributes to:
Impaired axonal transport
Synaptic loss
Neuronal dysfunction
Parkinson's Disease In Parkinson's disease, MAP4 involvement includes:
[α-Synuclein](/proteins/alpha-synuclein) interaction : Possible cross-talk with [alpha-synuclein](/proteins/alpha-synuclein) pathologyMicrotubule disruption : Lewy bodies may disrupt microtubule functionAxonal degeneration : Similar mechanisms to ADOther Neurodegenerative Conditions
Tauopathies : MAP4 is affected in all tauopathiesAmyotrophic lateral sclerosis (ALS) : Microtubule dysfunctionHuntington's disease : Axonal transport impairmentTherapeutic Implications
Kinase Inhibitors Targeting kinases that phosphorylate MAP4:
GSK-3β inhibitors : Lithium, tideglusibCDK5 inhibitors : Roscovitine derivativesMicrotubule-stabilizing Agents Drugs that stabilize microtubules bypass MAP4 dysfunction:
Taxanes : Paclitaxel, docetaxel (limited CNS penetration)Epothilones : Better CNS penetrationPhosphorylation-modulating Approaches
Protein phosphatase activators
Kinase inhibitors
Research Findings Key findings from recent research:
MAP4 phosphorylation is an early event in AD progression
Genetic variants of MAP4 may modify AD risk
MAP4 aggregates are found in aging brains
See Also
[MAP4 Gene](/genes/map4)
[Tau Protein](/proteins/4r-tau)
[Microtubule Function](/mechanisms/microtubule-function)
[Axonal Transport](/mechanisms/axonal-transport)
[Alzheimer's Disease Pathogenesis](/mechanisms/alzheimers-disease-pathogenesis)
[MAP2 Protein](/proteins/map2-protein)
[MAP1S Protein](/proteins/map1s-protein)
References
[Drewes et al., MAP4 in tauopathies (1998) (1998)](https://doi.org/10.1016/S0166-2236(97)
[Barlow et al., MAP4 in neuronal function (2002) (2002)](https://doi.org/10.1002/cne.10425)
[Wang et al., MAP4 and axonal transport (2008) (2008)](https://doi.org/10.1016/j.neuroscience.2008.04.048)
[Bulinski et al., MAP4 phosphorylation in disease (2007) (2007)](https://doi.org/10.1016/j.tcb.2007.07.005)
[Unknown, Mandelkow & Mandelkow, Tau and MAPs in neurodegeneration (2019) (2019)](https://doi.org/10.1016/j.tcb.2019.01.003) Show full description